MXPA04003938A - Compuestos retinoides heterociclicos. - Google Patents

Compuestos retinoides heterociclicos.

Info

Publication number
MXPA04003938A
MXPA04003938A MXPA04003938A MXPA04003938A MXPA04003938A MX PA04003938 A MXPA04003938 A MX PA04003938A MX PA04003938 A MXPA04003938 A MX PA04003938A MX PA04003938 A MXPA04003938 A MX PA04003938A MX PA04003938 A MXPA04003938 A MX PA04003938A
Authority
MX
Mexico
Prior art keywords
retinoid compounds
compounds
heterocyclic retinoid
heterocyclic
cancer
Prior art date
Application number
MXPA04003938A
Other languages
English (en)
Inventor
Lapierre Jean-Marc
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA04003938A publication Critical patent/MXPA04003938A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)

Abstract

La presente invencion proporciona nuevos compuestos retinoides heterociclicos de formula (I)(Ver formula I)en donde R1 a R5, A, B, Z y n son como se definen en la descripcion y reivindicaciones. Los compuestos de la presente invencion son utiles para el tratamiento y/o prevencion de enfermedades tales como enfermedad pulmonar obstructiva cronica, cancer y trastornos dermatologicos.
MXPA04003938A 2001-10-31 2002-10-21 Compuestos retinoides heterociclicos. MXPA04003938A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33512901P 2001-10-31 2001-10-31
PCT/EP2002/011746 WO2003037882A1 (en) 2001-10-31 2002-10-21 Heterocyclic retinoid compounds

Publications (1)

Publication Number Publication Date
MXPA04003938A true MXPA04003938A (es) 2004-06-18

Family

ID=23310382

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003938A MXPA04003938A (es) 2001-10-31 2002-10-21 Compuestos retinoides heterociclicos.

Country Status (21)

Country Link
US (2) US6818652B2 (es)
EP (1) EP1442032B1 (es)
JP (1) JP4234599B2 (es)
KR (1) KR100706589B1 (es)
CN (1) CN1283635C (es)
AR (1) AR037129A1 (es)
AT (1) ATE360010T1 (es)
AU (1) AU2002363170B2 (es)
BR (1) BR0213678A (es)
CA (1) CA2464289C (es)
DE (1) DE60219659T2 (es)
ES (1) ES2283649T3 (es)
GT (1) GT200200225A (es)
MX (1) MXPA04003938A (es)
PA (1) PA8557301A1 (es)
PE (1) PE20030691A1 (es)
PL (1) PL370598A1 (es)
RU (1) RU2275367C2 (es)
TW (1) TW200302085A (es)
UY (1) UY27526A1 (es)
WO (1) WO2003037882A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006025395A1 (ja) * 2004-08-31 2008-05-08 慶彦 清水 キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895868A (en) * 1988-06-29 1990-01-23 Allergan, Inc. Thiochroman esters of phenols and terephthallates having retinoid-like activity
AU626881B2 (en) * 1988-07-14 1992-08-13 F. Hoffmann-La Roche Ag Benzofused heterocyclics used as pharmaceuticals
FR2713635B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5675024A (en) * 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
FR2746098B1 (fr) 1996-03-14 1998-04-30 Composes propynyl biaromatiques
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
FR2764604B1 (fr) * 1997-06-13 1999-09-10 Cird Galderma Composes bi-aromatiques relies par un radical propynylene ou allenylene et compositions pharmaceutiques et cosmetiques les contenant
DE60112741T2 (de) * 2000-05-02 2006-06-01 F. Hoffmann-La Roche Ag Gamma-selektive retinoide

Also Published As

Publication number Publication date
EP1442032B1 (en) 2007-04-18
RU2275367C2 (ru) 2006-04-27
US20030158178A1 (en) 2003-08-21
CA2464289A1 (en) 2003-05-08
EP1442032A1 (en) 2004-08-04
ES2283649T3 (es) 2007-11-01
DE60219659D1 (de) 2007-05-31
ATE360010T1 (de) 2007-05-15
KR100706589B1 (ko) 2007-04-11
BR0213678A (pt) 2004-10-26
RU2004116695A (ru) 2005-11-10
JP2005507421A (ja) 2005-03-17
US6818652B2 (en) 2004-11-16
US20050049238A1 (en) 2005-03-03
PE20030691A1 (es) 2003-08-18
CA2464289C (en) 2009-09-15
CN1578776A (zh) 2005-02-09
AU2002363170B2 (en) 2007-12-13
UY27526A1 (es) 2003-04-30
WO2003037882A1 (en) 2003-05-08
GT200200225A (es) 2003-06-19
PA8557301A1 (es) 2004-02-07
AR037129A1 (es) 2004-10-20
CN1283635C (zh) 2006-11-08
KR20050038586A (ko) 2005-04-27
JP4234599B2 (ja) 2009-03-04
TW200302085A (en) 2003-08-01
PL370598A1 (en) 2005-05-30
US7354931B2 (en) 2008-04-08
DE60219659T2 (de) 2008-01-17

Similar Documents

Publication Publication Date Title
RS20050361A (en) Novel medicament for the treatment of chronic obstructive pulmonary diseases
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA04003439A (es) Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
UA85559C2 (en) Aminobenzophenone compounds
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
EP1441724B8 (en) Methods of increasing endogenous testosterone levels
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
MXPA04003938A (es) Compuestos retinoides heterociclicos.
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
WO2004056762A3 (en) Novel aminobenzophenone compounds
TW200603801A (en) Novel dialkoxy-imidazopyridines
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
ATE328883T1 (de) Imidazopyridin-8-one
EA200500903A1 (ru) Силиловые простые эфиры
DE60203740D1 (de) Luminacine analoge und deren verwendung
SE0301798D0 (sv) New use IV

Legal Events

Date Code Title Description
FG Grant or registration